Citations (26)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Etsuko Maeshima, Yohei Kida, Mikako Goda & Yoshinobu Minami. (2006) A case of systemic lupus erythematosus expressing intractable thrombocytopenia remedied effectively by intermittent and continuous administrations of a small amount of immune globulin. Modern Rheumatology 16:4, pages 239-242.
Read now
Read now
Articles from other publishers (25)
Lauren Ambler Robinson, Marissa Dale & Mark Gorelik. (2023) Multisystem Inflammatory Syndrome in Children and Kawasaki Disease. Rheumatic Disease Clinics of North America 49:3, pages 661-678.
Crossref
Crossref
C. Galeotti, F. Bajolle, A. Belot, S. Biscardi, E. Bosdure, E. Bourrat, R. Cimaz, R. Darbon, P. Dusser, O. Fain, V. Hentgen, V. Lambert, A. Lefevre-Utile, C. Marsaud, U. Meinzer, L. Morin, M. Piram, O. Richer, J.-L. Stephan, D. Urbina & I. Kone-Paut. (2023) French national diagnostic and care protocol for Kawasaki disease. La Revue de Médecine Interne 44:7, pages 354-380.
Crossref
Crossref
Diego Estrada-Luna, Elizabeth Carreón-Torres, Susana González-Reyes, María Fernanda Martínez-Salazar, María Araceli Ortiz-Rodríguez, Esther Ramírez-Moreno, José Arias-Rico & Angélica Saraí Jiménez-Osorio. (2022) Nutraceuticals for Complementary Treatment of Multisystem Inflammatory Syndrome in Children: A Perspective from Their Use in COVID-19. Life 12:10, pages 1652.
Crossref
Crossref
Dharmagat Bhattarai, Rajni Kumrah, Anit Kaur, Anupriya Kaur, Priyanka Srivastava, Amit Rawat & Surjit Singh. (2021) Association of ITPKC gene polymorphisms rs28493229 and rs2290692 in North Indian children with Kawasaki disease. Pediatric Research 92:4, pages 1090-1098.
Crossref
Crossref
Wendy Lee, Chooi San Cheah, Siti Aisyah Suhaini, Abdullah Harith Azidin, Mohammad Shukri Khoo, Noor Akmal Shareela Ismail & Adli Ali. (2022) Clinical Manifestations and Laboratory Findings of Kawasaki Disease: Beyond the Classic Diagnostic Features. Medicina 58:6, pages 734.
Crossref
Crossref
Dayoon Kwon, Young June Choe, Sun‐Young Kim, Byung Chul Chun & Seung‐Ah Choe. (2022) Ambient Air Pollution and Kawasaki Disease in Korean Children: A Study of the National Health Insurance Claim Data. Journal of the American Heart Association 11:9.
Crossref
Crossref
Elif Seda Selamet Tierney, Kyle Runeckles, Adriana H. Tremoulet, Nagib Dahdah, Michael A. Portman, Andrew S. Mackie, Ashraf S. Harahsheh, Sean M. Lang, Nadine F. Choueiter, Jennifer S. Li, Cedric Manlhiot, Tisiana Low, Mathew Mathew, Kevin G. Friedman, Geetha Raghuveer, Kambiz Norozi, Jacqueline R. Szmuszkovicz, Brian W. McCrindle, Carolyn A. Altman, Elizabeth Braunlin, Jane C. Burns, Michael R. Carr, Jessica H. Colyer, Frederic Dallaire, Adam Dempsey, Laurent Desjardins, Rejane Dillenburg, Audrey Dionne, Michael Gewitz, Therese M. Giglia, Kevin C. Harris, Kevin D. Hill, Supriya Jain, Pei-Ni Jone, Thomas R. Kimball, Shelby Kutty, Lillian Lai, Simon Lee, Ming-Tai Lin, William T. Mahle, Kimberly E. McHugh, Tapas Mondal, Jane W. Newburger, Claudia Renaud, S. Kristen Sexson Tejitel, Karen M. Texter, Deepika Thacker, Thomas Thomas, Sharon Wagner-Lees, Kenny K. Wong, Mei-Hwan Wu, Anji T. Yetman, Annette L. Baker, Tanveer Collins, Sarah D. De Ferranti, Anne Fournier, Patrick Gould, Sunita O’Shea, Craig A. Sable, Sam Sabouni & Devin D. Tinker. (2022) Variation in Pharmacologic Management of Patients with Kawasaki Disease with Coronary Artery Aneurysms. The Journal of Pediatrics 240, pages 164-170.e1.
Crossref
Crossref
Günther Dannecker & Toni Hospach. 2022. Pädiatrische Rheumatologie. Pädiatrische Rheumatologie
621
639
.
Si-Yuan Lin, Lan He, Li-Ping Xie, Yin Wang, Yi-Xiang Lin, Yin-Yin Cao, Wei-Li Yan, Fang Liu & Guo-Ying Huang. (2021) Effects of immunoglobulin plus prednisolone in reducing coronary artery lesions in patients with Kawasaki disease: study protocol for a phase III multicenter, open-label, blinded-endpoints randomized controlled trial. Trials 22:1.
Crossref
Crossref
Lan He, Fang Liu, Weili Yan, Min Huang, Meirong Huang, Lijian Xie, Ying Guo, Xinyi Xu, Chen Chu, Lin Wu, Xuecun Liang, Shuna Sun, Feng Wang, Lu Zhao, Quming Zhao, Xiaojing Ma, Liping Xie & Guoying Huang. (2021) Randomized trial of different initial intravenous immunoglobulin regimens in Kawasaki disease. Pediatrics International.
Crossref
Crossref
Ryan Lucas, Peta Dennington, Erica Wood, Audrey Dionne, Sarah D Ferranti, Jane W Newburger, Nagib Dahdah, Allen Cheng, David Burgner & Davinder Singh‐Grewal. (2020) Variation in the management of Kawasaki disease in Australia and New Zealand: A survey of paediatricians. Journal of Paediatrics and Child Health 57:5, pages 646-652.
Crossref
Crossref
Masaaki Mori, Susumu Yamazaki & Takuya Naruto. (2021) The Benefits and Respective Side-Effects of PE Therapy for Intractable Kawasaki Disease. Journal of Clinical Medicine 10:5, pages 1062.
Crossref
Crossref
Bernadette Goudreau, Manasa Kanneganti & Margaret Tracci. 2021. Vascular Disease in Women. Vascular Disease in Women
273
294
.
Günther Dannecker & Toni Hospach. 2020. Pädiatrische Rheumatologie. Pädiatrische Rheumatologie
1
19
.
Günther Dannecker & Toni Hospach. 2020. Pädiatrische Rheumatologie. Pädiatrische Rheumatologie
1
19
.
Sarah Reynolds, Seilesh Kadambari, Elizabeth Calton & Damian Roland. (2020) The child with prolonged fever: when to think zebras. Paediatrics and Child Health 30:7, pages 261-269.
Crossref
Crossref
Shani Ma, So Yung Choi, Hyeong Jun Ahn, Andrea M. Siu, Marian E. Melish & Andras Bratincsak. (2020) The Importance of Echocardiogram during the Second Week of Illness in Children with Kawasaki Disease. The Journal of Pediatrics 218, pages 72-77.e1.
Crossref
Crossref
Maryam Piram, Martha Darce Bello, Stéphanie Tellier, Sylvie Di Filippo, Franck Boralevi, Fouad Madhi, Ulrich Meinzer, Rolando Cimaz, Celine Piedvache & Isabelle Koné-Paut. (2020) Defining the risk of first intravenous immunoglobulin unresponsiveness in non-Asian patients with Kawasaki disease. Scientific Reports 10:1.
Crossref
Crossref
Aura A. Sanchez, Sara K. Sexson Tejtel, Myriam E. Almeida‐Jones, Douglas K. FeaginJrJr, Carolyn A. Altman & Ricardo H. Pignatelli. (2019) Comprehensive left ventricular myocardial deformation assessment in children with Kawasaki disease. Congenital Heart Disease 14:6, pages 1024-1031.
Crossref
Crossref
Audrey Dionne, Jane W. Newburger & Kevin G. Friedman. (2019) Acute Kawasaki Disease Therapy. Current Treatment Options in Pediatrics 5:3, pages 293-300.
Crossref
Crossref
Hyun Jeong Do, Jin Hee Jeong, Dong Hoon Kim, Tae Yun Kim, Changwoo Kang, Soo Hoon Lee & Sang Bong Lee. (2019) Comparison of acute phase reactant levels of Kawasaki disease patients who visited with less than 5 days duration of fever and with 5 days or longer. Pediatric Emergency Medicine Journal 6:1, pages 11-16.
Crossref
Crossref
Erdal Sag, Ezgi Deniz Batu & Seza Ozen. (2017) Childhood systemic vasculitis. Best Practice & Research Clinical Rheumatology 31:4, pages 558-575.
Crossref
Crossref
Brian W. McCrindle, Anne H. Rowley, Jane W. Newburger, Jane C. Burns, Anne F. Bolger, Michael Gewitz, Annette L. Baker, Mary Anne Jackson, Masato Takahashi, Pinak B. Shah, Tohru Kobayashi, Mei-Hwan Wu, Tsutomu T. Saji & Elfriede Pahl. (2017) Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association. Circulation 135:17.
Crossref
Crossref
Kyung Lim YoonHae Yong LeeJeong Jin YuJae Young LeeMi Young HanKi Yong KimJune Huh. (2017) Multicenter, Single-Arm, Phase IV Study of Combined Aspirin and High-Dose “IVIG-SN” Therapy for Pediatric Patients with Kawasaki Disease. Korean Circulation Journal 47:2, pages 209.
Crossref
Crossref
Hirohisa Kato & Kenji Suda. 2012. Pediatric Cardiovascular Medicine. Pediatric Cardiovascular Medicine
919
937
.